nav-left cat-right

Introduction to QC Kinetix

Stem cells can be present in almost all multicellular species, if not all. They are the body’s building blocks, capable of renewing themselves by mitotic cell division and differentiating into a variety of specialized cell types such as muscle or nerve cells. Scientists are studying how to tinker with stem cells so that they can be used to cure diseases like Alzheimer’s and Parkinson’s.Do you want to learn more? Visit QC Kinetix (Raleigh)
IVF was initially frowned upon, but it is now widely recognized as a standard and relatively routine procedure. Given enough time to raise awareness of the benefits of stem cell therapy, it is expected to become commonplace, similar to IVF. In reality, cell therapy is currently being used to treat leukemia patients, indicating that there is some public support of this method of treatment.
The Parkinson’s Society, for example, is promoting the use of stem cell therapy because of the disease’s existence. Those who suffer from slowly degenerative disorders are the ones who are most likely to lobby for human clinical trials. While it may be too late to save them, they are eager to assist in the treatment of future victims in the hopes of completely eliminating the disease. Furthermore, we have an ageing population, which is yet another explanation for the increased demand for cell and organ replacement therapy studies.
It’s important to remember that stem cell therapy has a commercial component. Established therapies could be phased out in favour of stem cell therapy in the future. For those with age-related oracular degeneration (AMD), for example, the current therapy is a 4 to 6 weekly injection in the diseased eye at a cost of £1,200 per injection. Embryonic stem cells could be used to replace these injections. A treatment that would take 40 minutes and last 2 to 3 years at a cost of about £5,000 would take 40 minutes and last 2 to 3 years. 1st This is only one example of a significant cost savings and, more significantly, an increase in the patient’s quality of life.